Nanoparticles for Stem Cell Therapy Bioengineering in Glioma

Henry Ruiz-Garcia, Keila Alvarado-Estrada, Sunil Krishnan, Alfredo Quinones-Hinojosa, Daniel M. Trifiletti

Research output: Contribution to journalReview articlepeer-review


Gliomas are a dismal disease associated with poor survival and high morbidity. Current standard treatments have reached a therapeutic plateau even after combining maximal safe resection, radiation, and chemotherapy. In this setting, stem cells (SCs) have risen as a promising therapeutic armamentarium, given their intrinsic tumor homing as well as their natural or bioengineered antitumor properties. The interplay between stem cells and other therapeutic approaches such as nanoparticles holds the potential to synergize the advantages from the combined therapeutic strategies. Nanoparticles represent a broad spectrum of synthetic and natural biomaterials that have been proven effective in expanding diagnostic and therapeutic efforts, either used alone or in combination with immune, genetic, or cellular therapies. Stem cells have been bioengineered using these biomaterials to enhance their natural properties as well as to act as their vehicle when anticancer nanoparticles need to be delivered into the tumor microenvironment in a very precise manner. Here, we describe the recent developments of this new paradigm in the treatment of malignant gliomas.

Original languageEnglish (US)
Article number558375
JournalFrontiers in Bioengineering and Biotechnology
StatePublished - Dec 7 2020


  • bioengineering
  • biomaterials
  • glioma
  • nanoparticles
  • nanotechnology
  • stem cells
  • surface functionalization
  • targeting

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Histology
  • Biomedical Engineering


Dive into the research topics of 'Nanoparticles for Stem Cell Therapy Bioengineering in Glioma'. Together they form a unique fingerprint.

Cite this